173 related articles for article (PubMed ID: 22069752)
1. Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
Reason D; Liberato J; Sun J; Camacho J; Zhou J
Toxins (Basel); 2011 Aug; 3(8):979-90. PubMed ID: 22069752
[TBL] [Abstract][Full Text] [Related]
2. Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.
Reason D; Liberato J; Sun J; Keitel W; Zhou J
Infect Immun; 2009 May; 77(5):2030-5. PubMed ID: 19223482
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
[TBL] [Abstract][Full Text] [Related]
4. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
Brossier F; Lévy M; Landier A; Lafaye P; Mock M
Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization.
Smith K; Crowe SR; Garman L; Guthridge CJ; Muther JJ; McKee E; Zheng NY; Farris AD; Guthridge JM; Wilson PC; James JA
Vaccine; 2012 Jun; 30(28):4276-83. PubMed ID: 22425791
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane-penetrating loop.
Hoelzgen F; Zalk R; Alcalay R; Cohen-Schwartz S; Garau G; Shahar A; Mazor O; Frank GA
Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1197-1205. PubMed ID: 34473089
[TBL] [Abstract][Full Text] [Related]
9. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
[TBL] [Abstract][Full Text] [Related]
11. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
[TBL] [Abstract][Full Text] [Related]
12. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
Little SF; Webster WM; Fisher DE
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
[TBL] [Abstract][Full Text] [Related]
14. Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.
Ngundi MM; Meade BD; Little SF; Quinn CP; Corbett CR; Brady RA; Burns DL
Clin Vaccine Immunol; 2012 May; 19(5):731-9. PubMed ID: 22441391
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
Kelly-Cirino CD; Mantis NJ
Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
[TBL] [Abstract][Full Text] [Related]
16. Domain specificity of the human antibody response to Bacillus anthracis protective antigen.
Reason DC; Ullal A; Liberato J; Sun J; Keitel W; Zhou J
Vaccine; 2008 Jul; 26(32):4041-7. PubMed ID: 18565627
[TBL] [Abstract][Full Text] [Related]
17. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
Pohl MA; Rivera J; Nakouzi A; Chow SK; Casadevall A
Infect Immun; 2013 Jun; 81(6):1880-8. PubMed ID: 23509144
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.
Gubbins MJ; Berry JD; Corbett CR; Mogridge J; Yuan XY; Schmidt L; Nicolas B; Kabani A; Tsang RS
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):436-43. PubMed ID: 16872381
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.
Winterroth L; Rivera J; Nakouzi AS; Dadachova E; Casadevall A
Infect Immun; 2010 Jun; 78(6):2890-8. PubMed ID: 20385755
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.
Clement KH; Rudge TL; Mayfield HJ; Carlton LA; Hester A; Niemuth NA; Sabourin CL; Brys AM; Quinn CP
Clin Vaccine Immunol; 2010 Nov; 17(11):1753-62. PubMed ID: 20739500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
